Hiroko Kawagoe-Takaki

Loss-of-Function Mutation in the Dioxygenase-Encoding FTO Gene Causes Severe Growth Retardation and Multiple Malformations

Sarah Boissel, Orit Reish, Karine Proulx et al. · The American Journal of Human Genetics · 2009 · 394 citations · Full text

Multiple Malformations, Developmental Biology, Loss-of-function Mutation +9

Prevalence of Loss-of-Function <i>FTO</i> Mutations in Lean and Obese Individuals

Karine Proulx, Hiroko Kawagoe-Takaki, Vincent Vatin et al. · Diabetes · 2009 · 103 citations · Full text

Pharmacological Characterization of a New, Orally Active and Potent Allosteric Metabotropic Glutamate Receptor 1 Antagonist, 4-[1-(2-Fluoropyridin-3-yl)-5-methyl-1 H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2 H)-carboxamide (FTIDC)

Gentaroh Suzuki, Toshifumi Kimura, Akio Satow et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 67 citations

Unique Antipsychotic Activities of the Selective Metabotropic Glutamate Receptor 1 Allosteric Antagonist 2-Cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one

Akio Satow, Gentaroh Suzuki, Shunsuke Maehara et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 47 citations

Correlation of Receptor Occupancy of Metabotropic Glutamate Receptor Subtype 1 (mGluR1) in Mouse Brain With In Vivo Activity of Allosteric mGluR1 Antagonists

Gentaroh Suzuki, Hiroko Kawagoe-Takaki, Takao Inoue et al. · Journal of Pharmacological Sciences · 2009 · 17 citations · Full text